Fenofibrate
Generic / Active Ingredient
What is Fenofibrate used for?
Hypertriglyceridaemia
19 Fenofibrate brands in Bangladesh
Compare prices across every brand of Fenofibrate and pick the most affordable option.
| Brand | Strength | Form | Manufacturer | Price |
|---|---|---|---|---|
| EnoFab | 200 mg | Capsule | Innovative Pharma (Albion) | ৳ 5.90 |
| Fenatrol | 145 mg | Tablet | Drug International Ltd. | ৳ 8.00 |
| Fenatrol | 200 mg | Capsule | Drug International Ltd. | ৳ 7.00 |
| Fenobate | 200 mg | Capsule | Renata Limited | ৳ 7.00 |
| Fenocap | 200 mg | Capsule | Orion Pharma Ltd. | ৳ 7.06 |
| Fenocol | 200 mg | Capsule | Peoples Pharma Ltd. | ৳ 7.00 |
| Fenogard | 200 mg | Capsule | Al-Madina Pharmaceuticals Ltd. | ৳ 7.00 |
| Fenolid | 200 mg | Capsule | General Pharmaceuticals Ltd. | ৳ 7.05 |
| Fenorat | 200 mg | Capsule | Pacific Pharmaceuticals Ltd. | ৳ 7.00 |
| Fibre | 200 mg | Capsule | The White Horse Pharma | ৳ 7.00 |
| Lipidof | 200 mg | Capsule | ACME Laboratories Ltd. | ৳ 7.04 |
| Lipired | 200 mg | Capsule | Square Pharmaceuticals Ltd. | ৳ 7.04 |
| Lofat | 200 mg | Capsule | Beximco Pharmaceuticals Ltd. | ৳ 7.00 |
| Nofiate | 200 mg | Capsule | Incepta Pharmaceuticals Ltd. | ৳ 7.00 |
| Noficon | 200 mg | Capsule | Eskayef Pharmaceuticals Ltd. | ৳ 7.00 |
| Tigicon | 200 mg | Capsule | Aristopharma Ltd. | ৳ 7.00 |
| Tigirate | 200 mg | Capsule | Opsonin Pharma Ltd. | ৳ 7.06 |
| Tizabet | 200 mg | Capsule | ACI Limited | ৳ 7.02 |
| Trigent | 200 mg | Capsule | UniMed UniHealth | ৳ 7.00 |
Indication DetailsView
Fenofibrate is indicated for hyperlipidemias of type lla, llb, III, IV & V in patients who have not responded adequately to diet & other appropriate measures.
Therapeutic ClassView
Fibrates
PharmacologyView
Fenofibrate is a fibric acid derivative. Fenofibrate is rapidly hydrolyzed after oral ingestion to its pharmacologically active form, fenofibric acid. Fenofibric acid produces reductions in total cholesterol, LDL cholesterol, Apo-lipoprotein B, Total triglycerides and VLDL. In addition, treatment with Fenofibrate results in increases in HDL and apo-proteins apoAI apoAII. Fenofibrate also reduces serum uric acid levels in hyperuricemic and normal individuals by increasing the urinary excretion of uric acid. The micronised form of Nofiate (Fenofibrate) has enhanced absorption over the non-micronised formulation.
DosageView
- For the treatment of adult patients with hypercholesterolemia or mixed hyperlipidemia, the initial dose of Fenofibrate is 200 mg per day.
- For adult patients with hypertriglyceridemia, the initial dose is 67 to 200 mg per day.
- Dose should be individualized according to patient response. Fenofibrate should be given with meal there by, optimizing the bioavailability of the medication. Or, as directed by the registered physician.
Side EffectsView
Gastro-intestinal (e.g. nausea, anorexia, gastric pain), pruritus, urticaria, impotence, also headache, dizziness, vertigo, fatigue, hair loss; myotoxicity.
ContraindicationsView
Fenofibrate is contraindicated in patients with hypersensitivity to Fenofibrate, severe renal or hepatic impairment, existing gall bladder disease, breast feeding mothers, photosensitivity to ketoprofen.
PrecautionsView
Special care needed in patients with renal disease, as progressive increases in serum creatinine concentration or failure to follow dosage guidelines may result in myotoxicity; discontinue if myotoxicity suspected or creatinine kinase concentration increases significantly. Liver function tests recommended every 3 months for first year.
InteractionsView
Fenofibrate has been reported to potentiate the anticoagulant effects of warfarin. When administered with antidiabetic drug it may improve glucose tolerance and have additive effect. Fenofibrate may also increase the nephrotoxicity of cyclosporine. Due to a potential increase in the risk of rhabdomyolysis, cautions should be taken against the use of Fenofibrate with HMG-CoA reductase inhibitors. However, the use of low-dose statins with Fenofibrate appears to be well tolerated.
Pregnancy & LactationView
Fenofibrate is not recommended for pregnant women.
Overdose EffectsView
There is no specific treatment for overdose with Fenofibrate. General supportive care of the patients is indicated, including monitoring of vital signs and observation of clinical status, should an overdose occur. Because Fenofibrate is highly bound to plasma proteins, hemodialysis should not be considered.
Storage ConditionsView
Do not store above 30°C. Keep away from light and out of the reach of children.